Howard Hughes Medical Institute’s Lennar Class A LEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-47
Closed -$4.83K 289
2025
Q4
$4.83K Sell
47
-2
-4% -$242 ﹤0.01% 351
2025
Q3
$6.18K Sell
49
-1
-2% -$124 ﹤0.01% 295
2025
Q2
$5.53K Buy
+50
New +$5.42K ﹤0.01% 304
2017
Q4
Sell
-105,056
Closed -$5.28M 30
2017
Q3
$5.28M Sell
105,056
-41,115
-28% -$2.05M 1.31% 18
2017
Q2
$7.42M Sell
146,171
-11,413
-7% -$562K 1.35% 12
2017
Q1
$7.68M Buy
157,584
+78,792
+100% +$3.57M 1.41% 9
2016
Q4
$3.22M Buy
+78,792
New +$3.19M 0.74% 34

Other funds holding LEN

Howard Hughes Medical Institute's LEN Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Lennar Class A (LEN) in Q1 2026, closing a stake of 47 shares — an estimated $4.83K sold.

Howard Hughes Medical Institute first reported a position in LEN in Q4 2016 and held it in 7 quarters. The position peaked at $7.68M in Q1 2017. 934 funds tracked by Wall St. Rank hold LEN as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Lennar Class A position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 47 Lennar Class A shares in Q1 2026, an estimated $4.83K.
  • Howard Hughes Medical Institute first reported a position in Lennar Class A in Q4 2016 and held it in 7 quarters.
  • Howard Hughes Medical Institute's Lennar Class A position peaked at $7.68M in Q1 2017.
  • 934 funds tracked by Wall St. Rank held Lennar Class A as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.